Page last updated: 2024-08-24

5-methylcytosine and Diabetic Glomerulosclerosis

5-methylcytosine has been researched along with Diabetic Glomerulosclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bi, SH; Biekedawulaiti, G; Chen, HY; Chen, L; Chu, JL; Du, LW; Duolikun, M; He, Y; Li, LL; Lin, J; Ma, RY; Maimaiti, Y; Tie, L; Wan, XY; Wang, ZH; Yang, ZQ; Zhang, L; Zheng, MZ1

Other Studies

1 other study(ies) available for 5-methylcytosine and Diabetic Glomerulosclerosis

ArticleYear
5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney disease.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: 5-Methylcytosine; Animals; Cell-Free Nucleic Acids; Diabetes Mellitus; Diabetic Nephropathies; Humans; Mice; Myeloid Differentiation Factor 88

2022